AllanJ. D., MoelleringR. C.: Antimicrobial combinations in the therapy of infections due to Gram-negative bacilli. Amer. J. Med., 8; 78, 65 (1985).
2.
BallA. P.: Clavulanic acid and amoxycillin: a clinical, bacteriological and pharmacological study. Lancet, 2; 620 (1980).
3.
BeeuwkesH., RutgersV. H.: A combination of amoxycillin and clavulanic acid in the treatment of respiratory tract infections caused by amoxycillin-resistant Haemophilus influenzae. Infection, 9; 244 (1981).
4.
BrogdenR. N.: Amoxycillin - clavulanic acid: a review of its antibacterial activity. pharmacokinetic and therapeutic use. Drugs, 22; 337 (1981).
5.
BrownA. G., ButterworthD., ColeM., HanscombG., HoodJ. D., ReadingC., RolisonG. N.: Naturally occuring beta-lactamases inhibitors with antibacterial activity. J. Antimicrob., 29; 668 (1976).
6.
CatherallE. J., MizenL.: Protection of amoxycillin and ticarcillin with clavulanic acid from inactivation by beta-lactamases in an erperimental localized infection. Drugs Exptl. Clin. Res., 10; 697 (1984).
7.
ClaraF.: Chemiothérapie anti-infectieuse. Méd. et Hyg., 43; 16 (1985).
8.
GreenwoodD., O'GradyF., BakerP.: An in vitro evaluation of clavulanic acid, a potent broal-spectrum beta-lactamases inhibitor. J. Antimicrob. Chemother., 5; 539 (1979).
9.
GoldsteinF. W.: Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections. J. Antimicrob. Chemother., 5; 705 (1979).
10.
MartinelliR.: Amoxycillin - clavulanic acid in the treatment of urinary tract infection due to Gram-negative bacteria resistant to penicillin. Antimicrob. Agents Chemother., 20; 800 (1981).
11.
SchaadU. B.: Single-dose pharmacokinetics of intravenous clavulanic acid with amoxycillin in pediatric patients. Antimicrob. Agents Chemother., 23; 252 (1983).
UlmerW. T., ZimmermanI.: A controlled trial of amoxycillin with clavulanic acid (BRL 25000) against doxycycline in chronic bronchitis. J. Intern. Med. Res., 9; 372 (1983).
